Furthermore, TGF-β signalling is dysregulated in diseases such as endometriosis (Ruiz-Meana et al., 1999; Ni and Li, 2017) and endometrial cancer (Kriseman et al., 2019; Monsivais et al., 2019). This evidence concerns the gene TGFB1 and endometriosis.